000 | 01936 a2200577 4500 | ||
---|---|---|---|
005 | 20250516042822.0 | ||
264 | 0 | _c20120111 | |
008 | 201201s 0 0 eng d | ||
022 | _a1873-2518 | ||
024 | 7 |
_a10.1016/j.vaccine.2011.05.096 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGil, Cristina | |
245 | 0 | 0 |
_aEx vivo production of autologous whole inactivated HIV-1 for clinical use in therapeutic vaccines. _h[electronic resource] |
260 |
_bVaccine _cAug 2011 |
||
300 |
_a5711-24 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAIDS Vaccines _ximmunology |
650 | 0 | 4 | _aAntiretroviral Therapy, Highly Active |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aDendritic Cells _ximmunology |
650 | 0 | 4 | _aFlow Cytometry |
650 | 0 | 4 |
_aHIV Infections _xprevention & control |
650 | 0 | 4 |
_aHIV-1 _ximmunology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLeukocytes, Mononuclear _xvirology |
650 | 0 | 4 | _aSequence Analysis |
650 | 0 | 4 |
_aVaccines, Inactivated _ximmunology |
650 | 0 | 4 | _aViral Load |
650 | 0 | 4 | _aVirus Inactivation |
700 | 1 | _aCliment, Núria | |
700 | 1 | _aGarcía, Felipe | |
700 | 1 | _aHurtado, Carmen | |
700 | 1 | _aNieto-Márquez, Sara | |
700 | 1 | _aLeón, Agathe | |
700 | 1 | _aGarcía, M Teresa | |
700 | 1 | _aRovira, Cristina | |
700 | 1 | _aMiralles, Laia | |
700 | 1 | _aDalmau, Judith | |
700 | 1 | _aPumarola, Tomás | |
700 | 1 | _aAlmela, Manel | |
700 | 1 | _aMartinez-Picado, Javier | |
700 | 1 | _aLifson, Jeffrey D | |
700 | 1 | _aZamora, Laura | |
700 | 1 | _aMiró, José M | |
700 | 1 | _aBrander, Christian | |
700 | 1 | _aClotet, Bonaventura | |
700 | 1 | _aGallart, Teresa | |
700 | 1 | _aGatell, José M | |
773 | 0 |
_tVaccine _gvol. 29 _gno. 34 _gp. 5711-24 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.vaccine.2011.05.096 _zAvailable from publisher's website |
999 |
_c20934443 _d20934443 |